DTL is attending SOT 2024
March 2024DTL is attending the 63rd SOT (Society of Toxicology) annual meeting and ToxExpo for at the Salt Palace Convention Center in Salt Lake City along with Dr Clive Roper. This… Read More >
DTL is attending the 63rd SOT (Society of Toxicology) annual meeting and ToxExpo for at the Salt Palace Convention Center in Salt Lake City along with Dr Clive Roper. This… Read More >
DTL’s new publication with Clive Roper on skin integrity and effects on absorption of sucrose and testosterone. https://doi.org/10.1016/j.tiv.2023.105735
Clive graduated with a PhD in in vitro dermal metabolism and toxicology from Newcastle University. He joined Inveresk Research (acquired by Charles River in 2004) as a research officer to develop the in… Read More >
As Dermal Technology Laboratory Ltd enters its 15th year of operation, one of our founders, Professor Jon Heylings has decided to retire as Chairman of DTL. I, along with all… Read More >
Following the routine inspection the MHRA has issued DTL’s latest the Statement of Compliance for Good Laboratory Practice
A comparison of the in vitro dermal absorption of testosterone in human and pig skin is a featured article in the April 2018 edition of Toxicology In Vitro. The paper… Read More >
Further validation of DTLs in vitro compromised skin model has just been published in the January 2017 edition of the journal Toxicology In Vitro. This article is Open Access and… Read More >
The Grant of Appointment and Crystal Rose Bowl were officially presented to DTL at an event hosted by Keele University’s Vice-Chancellor, Prof. Trevor McMillan. During the event Dave said “We… Read More >
Following the routine inspection the MHRA has issued DTL’s latest the Statement of Compliance for Good Laboratory Practice. The next inspection is due in two and half years.
Dermal Technology Laboratory (DTL) has been awarded one of the most coveted accolades in UK business. In recognition of its international growth and success over the past five years. DTL,… Read More >